8th China In Vitro Diagnostics Industry Development Conference Announces Comprehensive Agenda and Files Prospectus

Stay true to the original aspiration and keep the mission firmly in mind.

The COVID-19 outbreak in early 2020 disrupted normal market dynamics, and the global epidemic prevention situation remains severe. In response to this sudden public health emergency, IVD companies reacted swiftly. Countless IVD professionals, demonstrating selflessness and courage in the face of danger, accelerated technological breakthroughs. They promptly provided ample “weapons” and “ammunition” for the fight against the pandemic, fully embodying the social responsibility, sense of mission, and R&D innovation capabilities of IVD enterprises. The year 2021 is poised to be a pivotal starting point for comprehensive economic recovery. For the in vitro diagnostics industry, this period represents both a major test of production capacity and a new opportunity for industrial transformation and development. Amid these emerging opportunities and challenges, the in vitro diagnostics sector is certain to enter a new phase of rapid growth.

The 8th China In Vitro Diagnostics (IVD) Industry Development Conference upholds its positioning at the forefront and highest vantage point of China’s IVD industry, covering the entire industrial chain including R&D, manufacturing, marketing, services, regulation, academia, talent, innovation, new technologies, technology transfer, and capital. Committed to promoting industrial progress and driving the development of the IVD sector, the conference focuses on exchanges and cooperation in areas such as industry development, trends, healthcare reform, market dynamics, business models, management, capital, scientific research, innovation, applications, technology transfer, and key raw materials. By effectively aligning with advanced domestic and international resources, it strives to build a premier academic exchange platform that fosters collaborative development, integrated competition and cooperation, and forward-looking advancement within China’s IVD industry. To this end, the 8th China In Vitro Diagnostics (IVD) Industry Development Conference is scheduled to be held grandly on March 29, 2021, at the Chongqing Yuelai International Convention Center.

This edition of the China In Vitro Diagnostics (IVD) Industry Development Conference invited renowned experts, scholars, and entrepreneurs from both domestic and international arenas to engage in in-depth exchanges and discussions on artificial intelligence, industry development, business models, innovative concepts, and cutting-edge trends at home and abroad, covering multiple dimensions, perspectives, specialties, and levels.

At that time, the “Voice of Innovation” 6th China Conference on Laboratory Medicine / Wiley International Academic Conference on In Vitro Diagnostics, co-organized by the Experimental Medicine Branch of the China Health Industry Enterprise Management Association and Wiley Publishing Group, will be held concurrently with the following events organized by the Medical Laboratory Industry Branch of the China Health Industry Enterprise Management Association: the “Bright·Lab” 4th Young Entrepreneurs Forum on In Vitro Diagnostics, the 3rd “China IVD Distribution Enterprises Forum,” and the 1st “China Forum on Key Raw Materials and Components for In Vitro Diagnostics.” Also taking place simultaneously will be the 18th China International Congress of Laboratory Medicine and Transfusion Instrumentation & Reagents Expo (CACLP) and the 1st China International Expo on Upstream Raw Materials, Manufacturing, and Supply Chain for In Vitro Diagnostics.